Prospective Measurement of Post-Treatment Lymphedema

NCT00495950 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2016-11-25

No results posted yet for this study

Summary

The goal of this study is to measure the amount of limb swelling (lymphedema) that sometimes occurs after melanoma treatment, and to find out how people feel and react to the diagnosis and treatment of melanoma.

Conditions

Interventions

BEHAVIORAL

Questionnaire

Questionnaires relating to symptoms experienced during and following standard cancer treatment.

Sponsors & Collaborators

  • Clinical Oncology Research Development Program

    collaborator UNKNOWN
  • National Cancer Institute (NCI)

    collaborator NIH
  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Janice N. Cormier, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00495950 on ClinicalTrials.gov